Radiotherapy for Gastrointestinal Cancer

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: closed (15 December 2023) | Viewed by 573

Special Issue Editors


E-Mail Website
Guest Editor
Department of Radiation Oncology, University of Nebraska Medical Center, 987521 Nebraska Medical Center, Clarkson Tower, Omaha, NE 68198, USA
Interests: gastrointestinal cancer; pediatric cancers; lung cancer; other general cancers and medical conditions that can be treated with radiation

E-Mail Website
Guest Editor
Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, China
Interests: clinical radiotherapy; the influence of radiation on tumor microenvironment

E-Mail Website
Guest Editor
Mayo Clinic Scottsdale-Phoenix, Arizona, Scottsdale, AZ, USA
Interests: central nervous system malignancies; thoracic oncology including lung cancers; gastrointestinal malignancies; genitourinary malignancies; proton beam radiotherapies with particular focus in scanning beam technologies; clinical trials

Special Issue Information

Dear Colleagues,

The focus of this Special Issue is on radiotherapy for gastrointestinal cancer. Gastrointestinal cancers account for 26% of the global cancer incidence burden and 35% of all cancer-related deaths.  Gastrointestinal cancers, therefore, present a major health problem. Gastrointestinal cancers include cancers of the esophagus, stomach, liver, bile duct, pancreas, small bowel, colon, rectum, and anus. These tumors frequently require a multi-modal treatment including a combination of radiotherapy, surgery, and chemotherapy. Radiotherapy can be carried out either before or after surgery, with or without concurrent chemotherapy.

Recent advances in modern medical imaging and radiotherapy technologies have improved the effectiveness, decreased the complications, and expanded the implications of radiotherapy. These advances include volumetric modulated arc therapy, stereotactic radiotherapy, real-time image-guided radiotherapy, and adaptive radiotherapy. We expect that the study of radiotherapy, combined with immunotherapy, novel radio-sensitizers, or radio-protectors, will improve the efficacy and safety of radiotherapy. In addition, the development of new radiopharmaceuticals directly and specifically facilitates the delivery of radiotherapy to cancer cells, especially in the liver.

In this Special Issue, we invite your contributions, either in the form of original research articles, reviews, or shorter perspective articles on all aspects related to the theme of “radiotherapy for gastrointestinal cancer” including radiation biology, physics, and oncology.

Prof. Dr. Chi Lin
Prof. Dr. Benhua Xu
Dr. Terence T. Sio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • radiation biology
  • radiation physics
  • radiation oncology
  • radiation therapy
  • radiotherapy
  • gastrointestinal cancer

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop